Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0129
+0.0019 (17.27%)
Aug 19, 2026, 3:43 PM EST
Emmaus Life Sciences Revenue
Emmaus Life Sciences had revenue of $6.32M in the quarter ending June 30, 2026, with 124.28% growth. This brings the company's revenue in the last twelve months to $15.53M, up 10.98% year-over-year. In the year 2025, Emmaus Life Sciences had annual revenue of $12.45M, down -25.22%.
Revenue (ttm)
15.53M
Revenue Growth
+10.98%
P/S Ratio
0.05
Revenue / Employee
470.61K
Employees
33
Market Cap
772.07K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.45M | -4.20M | -25.22% |
| Dec 31, 2024 | 16.65M | -12.94M | -43.73% |
| Dec 31, 2023 | 29.60M | 11.21M | 60.94% |
| Dec 31, 2022 | 18.39M | -2.22M | -10.77% |
| Dec 31, 2021 | 20.61M | -2.56M | -11.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Emmaus Life Sciences News
- 5 days ago - Emmaus Life Sciences Reports Quarterly Financial Results - Business Wire
- 5 months ago - Emmaus Life Sciences Reports Annual Financial Results - Business Wire
- 8 months ago - Emmaus Life Sciences enters license, distribution agreement with NeoImmuneTech - TheFly
- 8 months ago - Emmaus Life Sciences Announces Strategic Transaction - Business Wire
- 1 year ago - Emmaus Life Sciences receives FDA approval for Endari label changes - TheFly
- 1 year ago - Emmaus Life Sciences Receives FDA Approval for Endari® Label Enhancements - PRNewsWire
- 1 year ago - Emmaus Life Sciences Reports Improved Quarterly Financial Results - PRNewsWire
- 2 years ago - Emmaus Life Sciences appoints Willis Lee as CEO - TheFly